NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
BILLERICA, Mass., March 30, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…
Live webcast to be held March 31 discussing announcement VANCOUVER, Washington, March 30, 2022 (GLOBE…
Initiated IMPAHCT, a global Phase 2b/Phase 3 trial of AV-101 for pulmonary arterial hypertension (PAH)…
Phase 3 registrational trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM)…
NEWS RELEASEMarch 30, 2022, 4:30 PM EST / 22:30 CET MDxHealth to Participate in the…
– Completed dosing in older adults portion of Phase 1/1b clinical trial for IVX-121, a…
Strong rationale for development for Alport syndrome as ELOX-02 has demonstrated significant readthrough in COL4A5…
FORT WORTH, TX, March 30, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. Based in Fort…
Twirla Demand Grows with Cycles Dispensed and Total Prescriptions (TRx) Up 35% and 33% Respectively…
BDC-1001 for the treatment of patients with HER2-expressing solid tumors on track for recommended Phase…
Fourth quarter 2021 UPNEEQ product sales of $3.1 million, representing 39% growth over third quarter…
2021 net revenue increased 119% year-over-year to $14.0 million Fourth quarter 2021 net revenue increased…
— Enrollment continues in Phase 2 JUNIPER trial of ANG-3070 for the treatment of patients…
– Pipeline Includes Three New Chemical Entities with Clinical Proof-Of-Concept (POC) Following CRN04894 and CRN04777…
Results Further Support Clinical Proof-of-Concept for CRN04777 by Showing Dose-Dependent Decreases in Fasting and Sulfonylurea-Induced…
– Company strengthens strategic focus on rare disease and immuno-oncology assets and details expected upcoming…
Internet City, Dubai–(Newsfile Corp. – March 30, 2022) – LBank Exchange, a global digital asset…
SHANGHAI, Mar 31, 2022 – (ACN Newswire) – Weimob Inc (2013.HK) released its 2021 financial…
AMSTERDAM–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research…